Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 407

1.

Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.

Courtais C, Kuster N, Dupuy AM, Folschveiller M, Jreige R, Bargnoux AS, Guiot J, Lefebvre S, Cristol JP, Sebbane M.

Am J Emerg Med. 2013 Jan;31(1):215-21. doi: 10.1016/j.ajem.2012.07.017. Epub 2012 Sep 20.

PMID:
23000327
2.

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.

Crit Care. 2006;10(3):R96. Epub 2006 Jun 28.

3.

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM.

Chest. 2009 Sep;136(3):823-31. doi: 10.1378/chest.08-1981. Epub 2009 Apr 10.

4.

Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

Gordo-Remartínez S, Calderón-Moreno M, Fernández-Herranz J, Castuera-Gil A, Gallego-Alonso-Colmenares M, Puertas-López C, Nuevo-González JA, Sánchez-Sendín D, García-Gámiz M, Sevillano-Fernández JA, Álvarez-Sala LA, Andueza-Lillo JA, de Miguel-Yanes JM.

PLoS One. 2015 Jun 1;10(6):e0125212. doi: 10.1371/journal.pone.0125212. eCollection 2015.

5.

Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.

Bello S, Lasierra AB, Mincholé E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A.

Eur Respir J. 2012 May;39(5):1144-55. doi: 10.1183/09031936.00080411. Epub 2011 Nov 10.

6.

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.

Suberviola B, Castellanos-Ortega A, Llorca J, Ortiz F, Iglesias D, Prieto B.

Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542.

7.

Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.

Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.

J Intern Med. 2006 Dec;260(6):568-76.

8.

[Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].

Chen Y, Li C.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Feb;26(2):115-9. doi: 10.3760/cma.j.issn.2095-4352.2014.02.012. Chinese.

9.

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1426-34. doi: 10.1164/rccm.201003-0415OC. Epub 2010 Jul 16.

PMID:
20639437
10.

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

Schuetz P, Stolz D, Mueller B, Morgenthaler NG, Struck J, Mueller C, Bingisser R, Tamm M, Christ-Crain M.

BMC Infect Dis. 2008 Feb 28;8:22. doi: 10.1186/1471-2334-8-22.

11.

Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.

Bello S, Fandos S, Lasierra AB, Mincholé E, Panadero C, Simon AL, Gavin O, De Pablo F, Menendez R, Torres A.

Respir Med. 2015 Sep;109(9):1193-206. doi: 10.1016/j.rmed.2015.07.003. Epub 2015 Jul 14.

PMID:
26205553
12.

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.

España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.

J Infect. 2015 May;70(5):457-66. doi: 10.1016/j.jinf.2014.12.003. Epub 2014 Dec 11.

PMID:
25499199
13.

The value of procalcitonin level in community-acquired pneumonia in the ED.

Park JH, Wee JH, Choi SP, Oh SH.

Am J Emerg Med. 2012 Sep;30(7):1248-54. doi: 10.1016/j.ajem.2011.08.009. Epub 2011 Oct 24.

PMID:
22030193
14.

[Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].

Julián-Jiménez A, Timón Zapata J, Laserna Mendieta EJ, Sicilia-Bravo I, Palomo-de Los Reyes MJ, Cabezas-Martínez A, Laín-Terés N, Estebaran-Martín J, Lozano-Ancín A, Cuena-Boy R.

Enferm Infecc Microbiol Clin. 2014 Apr;32(4):225-35. doi: 10.1016/j.eimc.2013.04.015. Epub 2013 Oct 31. Spanish.

PMID:
24182623
15.

Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia.

Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, Miedinger D, Leuppi J, Tamm M, Mueller B, Mueller C.

J Intern Med. 2008 Aug;264(2):166-76. doi: 10.1111/j.1365-2796.2008.01934.x. Epub 2008 Feb 20.

16.

Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.

Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.

Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.

PMID:
24559907
17.

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.

Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, Legramante J, Galante A, Salerno G, Cardelli P, Di Somma S.

BMC Infect Dis. 2012 Aug 8;12:184.

18.

Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.

Claessens YE, Mathevon T, Kierzek G, Grabar S, Jegou D, Batard E, Loyer C, Davido A, Hausfater P, Robert H, Lavagna-Perez L, Bernot B, Plaisance P, Leroy C, Renaud B.

Intensive Care Med. 2010 May;36(5):799-809. doi: 10.1007/s00134-010-1818-4. Epub 2010 Mar 16.

PMID:
20232049
19.

Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.

Renaud B, Schuetz P, Claessens YE, Labarère J, Albrich W, Mueller B.

Chest. 2012 Dec;142(6):1447-54.

PMID:
22661450
20.

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T; CAPNETZ Study Group.

Intensive Care Med. 2007 Dec;33(12):2069-78. Epub 2007 Oct 16.

PMID:
17938883
Items per page

Supplemental Content

Write to the Help Desk